Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Zantac Cancer Risks Concealed By GlaxoSmithKline for Decades, Whistleblower Lawsuit Alleges Glaxo first discovered a link between NDMA in Zantac and cancer at least four decades ago, according to the lawsuit filed by the independent testing lab that uncovered the cancer risks associated with the heartburn drug May 21, 2024 Irvin Jackson Add Your Comments GlaxoSmithKline faces a whistleblower lawsuit brought by an independent testing laboratory, which discovered high rates of a cancer-causing chemical in Zantac in 2019, which led to a massive recall and tens of thousands of Zantac cancer lawsuits against the various manufacturers of the heartburn drug. Zantac (ranitidine) was used by millions of Americans before it was removed from the market by the U.S. Food and Drug Administration (FDA) in late 2019, following the discovery that the active pharmaceutical ingredient is inherently unstable and produces high levels of the chemical byproduct N-Nitrosodimethylamine (NDMA), which is a potent human carcinogen. The problem was first revealed by Valisure, an independent laboratory that regularly investigates popular consumer products for chemical and health risks. Valisure’s investigations have also uncovered the presence of benzene in aerosol sprays, leading to lawsuits against sunscreen products, deodorants and other products. In the wake of the Zantac recall, GlaxoSmithKline, Boehringer Ingelheim Pfizer, Sanofi and various other manufacturers, distributors, and retailers have faced more than 80,000 Zantac lawsuits brought throughout the U.S., including claims brought by former users who indicate were diagnosed with bladder cancer, liver cancer, pancreatic cancer, stomach cancer and other injuries after taking brand name Zantac or one of its generic equivalents. ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The original whistleblower lawsuit was filed under seal against GlaxoSmithKline in 2019. However, an amended complaint (PDF) was publicly released on the docket on May 20, after the U.S. government declined to intercede in the case. Valisure alleges that GlaxoSmithKline knew for decades about the cancer risks that may result from excessive levels of NDMA generated in the body after Zantac use, but concealed that information from federal regulators and the medical community, violating false claims act laws by the federal government and 25 states. One study indicated that GlaxoSmithKline, then known as just Glaxo, detected NDMA in Zantac as early as 1982, but failed to make the FDA aware of those results until after Valisure’s investigation in 2019. “When the FDA ordered GSK to disclose all its data about this issue due to the FDA’s concerns about the chemical structure of the ranitidine molecule, GSK concealed its data,” the lawsuit states. “In fact, GSK fabricated a different study, designed to conceal any NDMA connection, and then used that study to mislead the FDA and other independent researchers. GSK knowingly and deliberately lied to the FDA and the government so that it could get ranitidine approved.” While GSK has maintained that Valisure’s testing methods were faulty, it has agreed to make Zantac settlement payouts in several cases just before trial was set to begin. However, the drug maker did allow a recent claim brought by a woman diagnosed with colorectal cancer to go before a jury this month in Illinois state court, which is being closely watched to gauge how juries may respond to evidence over the Zantac cancer risks that will be repeated throughout thousands of other claims. May 2024 Zantac Cancer Lawsuit Update For several years, most of the litigation was focused in the federal court system, where all Zantac cancer lawsuits were centralized before Judge Robin L. Rosenberg in the U.S. District Court for the Southern District of Florida, for coordinated discovery and pretrial proceedings. However, in 2022 Judge Rosenberg issued a controversial ruling, determining that all of the plaintiffs’ expert witnesses were excluded from testifying at trial under federal evidentiary rules. While appeals have been filed to challenge Judge Rosenberg’s ruling, the decision has left federal plaintiffs without any means of proving the recalled Zantac pills caused their cancer, and all Zantac lawsuits pending in the federal court system have been dismissed. However, the federal ruling did not have any impact on lawsuits filed in Illinois, Delaware and various other state courts, where different standards for the admissibility of expert witness testimony apply. Large Zantac settlement agreements have been reached by both Pfizer and Sanofi, hoping to resolve their part in the litigation before having to undergo thousands of jury trials which could have varying, and expensive, results. Pfizer recently acknowledged that it intends to pay up to $250 million to resolve about 10,000 Zantac lawsuits in state courts. That came shortly after Sanofi announced a similar agreement to settle 4,000 Zantac cancer lawsuits for more than $100 million. Most of the remaining unresolved Zantac lawsuits involve claims against GlaxoSmithKline and Boehringer Ingelheim, who have failed to reach widespread settlements to resolve claims. Tags: Cancer, Delaware, GlaxoSmithKline, Heartburn, Heartburn Drug, NDMA, Pfizer, Sanofi, Whistleblower, Zantac, Zantac Recall More Zantac Lawsuit Stories Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)
GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers October 10, 2024
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer.
Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)